The anti-cancer and cancer treatment sector is strong; Ruizhi Pharmaceutical hits the daily limit.

MaticHoleFiller · 2026-04-01T09:33:10+00:00

As of 11:15, the anti-cancer and cancer treatment sector performed strongly, with multiple stocks hitting the daily limit. Stocks like Ruizhi Medicine led the gains. Investment should be cautious; information is for reference only and does not constitute investment advice.

MaticHoleFiller

2026-04-01 09:33:10

Abstract generation in progress

April 01 news, as of 11:15, the anti-cancer cancer-treatment sector is strong; Ruisai Pharmaceutical, Peking University Pharmaceutical, and Haixin Shares hit the daily limit, while gain leaders include Shuotai Shen, Xinli Tai, Tainkang, Changshan Pharmaceutical, Boteng Shares, and others.

Statement: The market involves risks; investment must be approached with caution. This article is automatically published based on a third-party database and does not represent Sina Finance’s views. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are discrepancies, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

A massive stream of information and precise analysis—right in the Sina Finance app

责任编辑：小浪快报

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.